We and others have previously proved that upregulation of stemness and EMT-related markers could confer tumor cells with CSC-like properties, and CD44+/CD24−/low cells were widely used to characterize the BCSC populations or tumor-initiating cells [34]. The gene discussed is CD44; the disease is neoplasm.